newscontact us


What is SurgWerks?

View our clinical pipeline here.

Cesca Therapeutics has designed a integrated protocol, disposable and equipment product for rapid intra-operative use in 90-120  minutes.

Components of the SurgWerks System include: 

  • Protocol : A defined standard operating procedure containing step-by-step instructions on the operation of all components necessary to produce a defined cellular dose starting from the collection of source material (ie. bone marrow) through final delivery to the patient.
  • Disposables : A complete sterile “single-use” procedure kit containing all medical disposables and testing reagents necessary to collect, process and deliver a defined therapeutic dose to the patient within the surgical suite.
  • Equipment :  The SurgWerks Processing Platform, including  all equipment/devices necessary to produce the defined cellular dose (ie. device and centrifuge for cell processing and concentration).

SurgWerks Procedure  Kit Diagram


Our vision is to provide fully optimized “kits” in compliance with the US FDA (or appropriate equivalent), which revolutionize how autologous cellular therapies are conducted.  At the core of successful clinical outcomes is the maintenance of cell viability and potency throughout the process of source material collection, target cell selection, characterization/dose determination, and final delivery of the cells to the patient.  Cesca is developing a unique and patent protected system designed to achieve cell manufacturing process control in a rapid 90-120 minute  process.

View our clinical pipeline here.